{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:20:23Z","timestamp":1729830023362,"version":"3.28.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,24]]},"DOI":"10.7759\/cureus.72301","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:23:20Z","timestamp":1729783400000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Efficacy of Novel Antiviral Therapies in Treating Hepatitis C"],"prefix":"10.7759","author":[{"given":"Fatima","family":"Amjad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Nabeel","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulaiman","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Usman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Qammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamna","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryyam","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8020092","article-title":"Genotypes of hepatitis C virus and efficacy of direct-acting antiviral drugs among chronic hepatitis C patients in a tertiary care hospital","volume":"8","author":"Hawsawi NM","year":"2023","unstructured":"Hawsawi NM, Saber T, Salama HM, et al.. Genotypes of hepatitis C virus and efficacy of direct-acting antiviral drugs among chronic hepatitis C patients in a tertiary care hospital. Trop Med Infect Dis. 2023, 8:92. 10.3390\/tropicalmed8020092","journal-title":"Trop Med Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v6.i13.589","article-title":"Update on global epidemiology of viral hepatitis and preventive strategies","volume":"6","author":"Jefferies M","year":"2018","unstructured":"Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases. 2018, 6:589-99. 10.12998\/wjcc.v6.i13.589","journal-title":"World J Clin Cases"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.7880","article-title":"Prevalence and predictors of hepatitis B in Jeddah City, Saudi Arabia: A population-based seroprevalence study","volume":"10","author":"Al-Raddadi RM","year":"2016","unstructured":"Al-Raddadi RM, Dashash NA, Alghamdi HA, et al.. Prevalence and predictors of hepatitis B in Jeddah City, Saudi Arabia: A population-based seroprevalence study. J Infect Dev Ctries. 2016, 10:1116-23. 10.3855\/jidc.7880","journal-title":"J Infect Dev Ctries"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_421_18","article-title":"Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions","volume":"25","author":"Aljumah AA","year":"2019","unstructured":"Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, Sanai FM. Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions. Saudi J Gastroenterol. 2019, 25:73-80. 10.4103\/sjg.SJG_421_18","journal-title":"Saudi J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111713","article-title":"Antioxidant and anti-inflammatory activity of Cynanchum acutum L. isolated flavonoids using experimentally induced type 2 diabetes mellitus: Biological and in silico investigation for NF-\u03baB pathway\/miR-146a expression modulation","volume":"10","author":"Abdelhameed RF","year":"2021","unstructured":"Abdelhameed RF, Ibrahim AK, Elfaky MA, et al.. Antioxidant and anti-inflammatory activity of Cynanchum acutum L. isolated flavonoids using experimentally induced type 2 diabetes mellitus: Biological and in silico investigation for NF-\u03baB pathway\/miR-146a expression modulation. Antioxidants (Basel). 2021, 10:1713. 10.3390\/antiox10111713","journal-title":"Antioxidants (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello A","year":"2016","unstructured":"Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016, 22:7824-40. 10.3748\/wjg.v22.i34.7824","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","unstructured":"Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017, 2:161-76. 10.1016\/S2468-1253(16)30181-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0873-7","article-title":"Hepatitis C virus genotypes in Saudi Arabia: A future prediction and laboratory profile","volume":"14","author":"Bawazir A","year":"2017","unstructured":"Bawazir A, AlGusheri F, Jradi H, AlBalwi M, Abdel-Gader AG. Hepatitis C virus genotypes in Saudi Arabia: A future prediction and laboratory profile. Virol J. 2017, 14:208. 10.1186\/s12985-017-0873-7","journal-title":"Virol J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-012-0251-8","article-title":"Prevalence of hepatitis C virus in a selected geographical area of northern India: A population based survey","volume":"31","author":"Sood A","year":"2012","unstructured":"Sood A, Sarin SK, Midha V, Hissar S, Sood N, Bansal P, Bansal M. Prevalence of hepatitis C virus in a selected geographical area of northern India: A population based survey. Indian J Gastroenterol. 2012, 31:232-6. 10.1007\/s12664-012-0251-8","journal-title":"Indian J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower E","year":"2014","unstructured":"Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014, 61:S45-57. 10.1016\/j.jhep.2014.07.027","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina JP","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015, 61:77-87. 10.1002\/hep.27259","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-50","article-title":"Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco","volume":"13","author":"Baha W","year":"2013","unstructured":"Baha W, Foullous A, Dersi N, et al.. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013, 13:50. 10.1186\/1471-2458-13-50","journal-title":"BMC Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-208","article-title":"Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh","volume":"10","author":"Ashraf H","year":"2010","unstructured":"Ashraf H, Alam NH, Rothermundt C, et al.. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis. 2010, 10:208. 10.1186\/1471-2334-10-208","journal-title":"BMC Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL Recommendations on Treatment of Hepatitis C 2016","volume":"66","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017, 66:153-94. 10.1016\/j.jhep.2016.09.001","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i3.616","article-title":"Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease","volume":"7","author":"Shaheen MA","year":"2015","unstructured":"Shaheen MA, Idrees M. Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease. World J Hepatol. 2015, 7:616-27. 10.4254\/wjh.v7.i3.616","journal-title":"World J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304021-assessing-the-efficacy-of-novel-antiviral-therapies-in-treating-hepatitis-c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:23:22Z","timestamp":1729783402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304021-assessing-the-efficacy-of-novel-antiviral-therapies-in-treating-hepatitis-c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.72301","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}